Alternative splicing

File:Pre-mRNA to mRNA.svg

Alternative splicing produces two protein isoforms.

Alternative splicing allows DNA to code for more than one protein. It varies the exon make-up of the messenger RNA.

In alternative splicing the exons of the pre-messenger RNA produced by transcription are reconnected in different ways during RNA splicing.

This produces different mature messenger RNAs from the same gene. They get translated into different proteins. Thus, a single gene may code for multiple proteins.[1]

Alternative splicing is normal in eukaryotes. It greatly increases the diversity of proteins that can be encoded by the genome.[1] In humans, ~95% of multiexonic genes are alternatively spliced.[2][3][4]

There are various kinds of alternative splicing: the most common is exon skipping. An exon may be included in mRNAs under some conditions or in particular tissues, and omitted from the mRNA in others.[1] There are splicing activators that promote the use of a particular splice site, and splicing repressors that reduce the use of a particular site. New types of alternative splicing are being found.[4][5]

Abnormal variations in splicing occur in disease. Many human genetic disorders come from splicing variants.[4] Abnormal splicing variants may also contribute to the development of cancer.[6][7][8] High-throughput sequencing of RNA can for example be used to measure the genome-scale amount of deviating alternative splicing, such as in a cohort of colorectal cancers, where high amount of aberrant splicing was associated to poor patient survival.[9] Non-working splicing products are usually dealt with by post-transcriptional quality control.[10] That is, they are chopped up by enzymes.

Source of diversity

Alternative splicing (the re-combination of different exons) is a major source of genetic diversity in eukaryotes. One particular Drosophila gene (DSCAM) can be alternatively spliced into 38,000 different mRNA.[11]

Alternative Splicing Media

Related pages

References

  1. 1.0 1.1 1.2 Black, Douglas L.. Mechanisms of alternative pre-messenger RNA splicing. Annual Reviews of Biochemistry 72 (1) (2003). p. 291–336. doi:10.1146/annurev.biochem.72.121801.161720.
  2. multiexonic: those genes where the coding sections (exons) are separated by non-coding sections (introns)
  3. Pan, Q. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics 40 (12) (2008). p. 1413–1415. doi:10.1038/ng.259.
  4. 4.0 4.1 4.2 Matlin, Arianne J.. Understanding alternative splicing: towards a cellular code. Nature Reviews 6 (5) (2005). p. 386–398. doi:10.1038/nrm1645.
  5. David, C.J.. The search for alternative splicing regulators: new approaches offer a path to a splicing code. Genes & Development 22 (3) (2008). p. 279–285. doi:10.1101/gad.1643108.
  6. Skotheim R.I. and Nees M. Alternative splicing in cancer: noise, functional, or systematic?. The International Journal of Biochemistry & Cell Biology 39 (7–8) (2007). p. 1432–49. doi:10.1016/j.biocel.2007.02.016.
  7. Bauer, Joseph Alan. A global view of cancer-specific transcript variants by subtractive transcriptome-wide analysis. PLOS ONE 4 (3) (2009). p. e4732. doi:10.1371/journal.pone.0004732.
  8. Fackenthal J; Godley L. Aberrant RNA splicing and its functional consequences in cancer cells. Disease Models & Mechanisms 1 (1) (2008). p. 37–42. doi:10.1242/dmm.000331.
  9. Deviating alternative splicing as a molecular subtype of microsatellite stable colorectal cancer. JCO Clinical Cancer Informatics 7 (7) (2023). p. e2200159. doi:10.1200/CCI.22.00159.
  10. Danckwardt S. Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. Blood 99 (5) (2002). p. 1811–6. doi:10.1182/blood.V99.5.1811.
  11. Schmucker D.. Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell 101 (6) (2000). p. 671–684. doi:10.1016/S0092-8674(00)80878-8.